Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
Colleoni, Marco, Luo, Weixiu, Karlsson, Per, Chirgwin, Jacquie, Aebi, Stefan, Jerusalem, Guy, Neven, Patrick, Hitre, Erika, Graas, Marie-Pascale, Simoncini, Edda, Kamby, Claus, Thompson, Alastair, LoiLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30715-5
Date:
November, 2017
File:
PDF, 433 KB
english, 2017